Ology Bioservices Inc Awarded $176M to advance the botulinum antitoxin monoclonal antibody cocktail
Ology Bioservices Inc.,* Alachua, Florida, was awarded a $176,286,308 cost-plus-fixed-fee contract to advance the botulinum antitoxin monoclonal antibody cocktail (Anti-BoNT A/B Drug Product G03-52-01) to Food and Drug Administration licensure. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion date of Jan. 3, 2028. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911SR-22-D-0009).
Ology Bioservices, Inc. is located in Alachua, FL, United States and is part of the Scientific Research and Development Services Industry. Ology Bioservices, Inc. has 103 total employees across all of its locations and generates $26.62 million in sales (USD). (Sales figure is modelled). There are 5 companies in the Ology Bioservices, Inc. corporate family. (www.dnb.com)